Shares of QuantaMatrix, an in-vitro diagnostics company specializing in sepsis diagnostics solutions, surged by 30 percent to 6,660 won ($4.82) on Thursday, after announcing that its ultra-rapid antimicrobial susceptibility testing (uRAST) technology has been featured in the journal Nature. This mar